Impact
High effect
Typical dose:400–1200 mg
S-Adenosyl Methionine is a naturally occurring molecule involved in methylation processes that reduce inflammation and stimulate the production of proteoglycans, a key component of cartilage. It has a dual-action benefit for both symptom relief and structural support.
- Focuses on
- Most relevant for
- Individuals with osteoarthritis looking for long-term symptom management who prefer an alternative with potentially fewer side effects than standard anti-inflammatory drugs.
Potential benefits
- Osteoarthritis Symptom Relief.Clinical trials indicate that SAMe may reduce joint pain and functional limitations, with some studies finding it as effective as standard anti-inflammatory medications for knee and hip osteoarthritis.
- Improved Physical Function.Research suggests that regular supplementation can help improve mobility and ease morning stiffness in individuals with degenerative joint issues.
- Cartilage Support.Unconfirmed. While laboratory studies suggest SAMe might stimulate cartilage production, there is currently no clinical evidence confirming that it can repair joint tissue or prevent further damage in humans.
Limitations
- Slower Onset.Significant improvements in joint comfort may take several weeks of consistent use, whereas traditional pain medications often provide faster initial relief.
- Inconclusive Evidence.Meta-analyses of placebo-controlled trials have yielded mixed results, suggesting that any benefits for pain and function might be small or limited by the quality of available studies.
- Insufficient Structural Data.Most clinical research focuses on subjective pain scales rather than objective measures like joint space narrowing, so its role in long-term joint preservation remains uncertain.
Things to consider
Clinical trials have reported mild gastrointestinal side effects in some users, though frequency is typically lower than that seen with common non-steroidal anti-inflammatory drugs.
Study evidence
9 studiesSAMe may ease osteoarthritis symptoms, but placebo-controlled evidence remains inconclusive and any benefit may be small. Some older trials found symptom relief comparable to anti-inflammatory medicines, without establishing that SAMe repairs cartilage or protects joints from further damage.
View goal
